Pre-eclampsia and the risk of cancerBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7445.909 (Published 15 April 2004) Cite this as: BMJ 2004;328:909
- Aliki Taylor, Cancer Research UK training fellow in cancer public health and epidemiology (A.J.Taylor@bham.ac.uk)
- Department of Public Health and Epidemiology, University of Birmingham, Birmingham B15 2TT
Several studies suggest a decreased risk—except this one
This issue of the BMJ includes a study which examines the relation between pre-eclampsia and cancer.1 Many researchers have suggested that pre-eclampsia or hypertension in pregnancy is associated with a reduced risk or no excess risk of cancer in the mother.2–8 However this week's study by Paltiel et al shows an increased risk of cancer after pre-eclampsia.1
Despite decades of research, there is still confusion over the cause of pre-eclampsia. It is relatively common, affecting 3-5% of pregnancies, and is a leading cause of morbidity and mortality both in the mother and unborn child.9 Several observational studies in European and North American populations have examined the relation between pre-eclampsia (or hypertension) in pregnancy and cancer.2–8 Unfortunately some were based on a small number of cancers in the pre-eclampsia group, not all adjusted for known confounders, and the length of follow up varied. Most of these studies found a …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.